NUT Carcinoma — Trials

NUT Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07050186	Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma	recruiting	Phase 2	15	Northwestern UniversityOTHER	1	Aug 18, 2026	clinicaltrials
NCT05019716	Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma	recruiting	Phase 1 / Phase 2	36	National Cancer Institute (NCI)NIH	1	Jul 31, 2026